Replimune (REPL) Non Operating Income (2017 - 2026)
Replimune (REPL) reported Non Operating Income of -$840,000 for fiscal Q2 2027 (quarter ended Sep 30, 2026), compared with $1.19 million a year earlier.
Powered by 
Analysis
Replimune (REPL) Non Operating Income (2017 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Replimune's Non Operating Income came in at -$1.85 million; for FY2026 (ended Mar 31, 2026), it was $5.43 million, down 63.3% from FY2025.
- By fiscal year, Non Operating Income came in at $14.8 million in FY2025 (-23.7%), $19.39 million in FY2024 (+528.6%), $3.08 million in FY2023 and $278,000 in FY2022.
- Five-year quarterly Non Operating Income spans a low of -$1.52 million in fiscal Q2 2023 and a high of $6.29 million in fiscal Q1 2024.
- Year over year, Non Operating Income gained in three of the last five quarters, with growth averaging 3.2%.
- The high point for year-over-year Non Operating Income in five years was fiscal Q3 2024 (growth of 203.8%); the low point was fiscal Q3 2025 (a decline of 95.7%).
- Per Business Quant data, the three fiscal quarters before Q2 2027 came in at -$1.52 million (Q1 2027), -$119,000 (Q4 2026) and $627,000 (Q3 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | -202.00 Mn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | - |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | - |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 1.63 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | -130.00 Mn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | - |
| 10 | Replimune | 2.40 Bn | 1.35 Bn | - | -840,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -840,000.00 |
| Jun 30, 2026 | -1.52 Mn |
| Mar 31, 2026 | -119,000.00 |
| Dec 31, 2025 | 627,000.00 |
| Sep 30, 2025 | 1.19 Mn |
| Jun 30, 2025 | 3.73 Mn |
| Mar 31, 2025 | 5.09 Mn |
| Dec 31, 2024 | 254,000.00 |
| Sep 30, 2024 | 5.86 Mn |
| Jun 30, 2024 | 3.60 Mn |
| Mar 31, 2024 | 3.62 Mn |
| Dec 31, 2023 | 5.89 Mn |
| Sep 30, 2023 | 3.59 Mn |
| Jun 30, 2023 | 6.29 Mn |
| Mar 31, 2023 | 4.04 Mn |
| Dec 31, 2022 | 1.94 Mn |
| Sep 30, 2022 | -1.52 Mn |
| Jun 30, 2022 | -1.38 Mn |
| Mar 31, 2022 | 292,000.00 |
| Dec 31, 2021 | 24,000.00 |
API Access
Replimune Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=REPL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "REPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=REPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();